Bausch Health Cos (BHC) Competitors $6.71 -0.16 (-2.33%) Closing price 07/8/2025 03:59 PM EasternExtended Trading$6.76 +0.04 (+0.67%) As of 07/8/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BHC vs. BPMC, BBIO, VRNA, ROIV, ELAN, RVMD, LEGN, GRFS, TGTX, and LNTHShould you be buying Bausch Health Cos stock or one of its competitors? The main competitors of Bausch Health Cos include Blueprint Medicines (BPMC), BridgeBio Pharma (BBIO), Verona Pharma PLC American Depositary Share (VRNA), Roivant Sciences (ROIV), Elanco Animal Health (ELAN), Revolution Medicines (RVMD), Legend Biotech (LEGN), Grifols (GRFS), TG Therapeutics (TGTX), and Lantheus (LNTH). These companies are all part of the "pharmaceutical products" industry. Bausch Health Cos vs. Its Competitors Blueprint Medicines BridgeBio Pharma Verona Pharma PLC American Depositary Share Roivant Sciences Elanco Animal Health Revolution Medicines Legend Biotech Grifols TG Therapeutics Lantheus Bausch Health Cos (NYSE:BHC) and Blueprint Medicines (NASDAQ:BPMC) are both mid-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, profitability, risk, analyst recommendations, media sentiment, institutional ownership, dividends and earnings. Do analysts rate BHC or BPMC? Bausch Health Cos presently has a consensus price target of $7.42, suggesting a potential upside of 10.53%. Blueprint Medicines has a consensus price target of $128.25, suggesting a potential downside of 0.12%. Given Bausch Health Cos' higher probable upside, equities research analysts clearly believe Bausch Health Cos is more favorable than Blueprint Medicines.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bausch Health Cos 1 Sell rating(s) 6 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.86Blueprint Medicines 0 Sell rating(s) 17 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 2.24 Which has more volatility and risk, BHC or BPMC? Bausch Health Cos has a beta of 0.41, suggesting that its share price is 59% less volatile than the S&P 500. Comparatively, Blueprint Medicines has a beta of 0.89, suggesting that its share price is 11% less volatile than the S&P 500. Does the media prefer BHC or BPMC? In the previous week, Blueprint Medicines had 4 more articles in the media than Bausch Health Cos. MarketBeat recorded 6 mentions for Blueprint Medicines and 2 mentions for Bausch Health Cos. Blueprint Medicines' average media sentiment score of 0.68 beat Bausch Health Cos' score of 0.23 indicating that Blueprint Medicines is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bausch Health Cos 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Blueprint Medicines 3 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals & insiders hold more shares of BHC or BPMC? 78.7% of Bausch Health Cos shares are held by institutional investors. 8.1% of Bausch Health Cos shares are held by company insiders. Comparatively, 4.2% of Blueprint Medicines shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has better valuation & earnings, BHC or BPMC? Bausch Health Cos has higher revenue and earnings than Blueprint Medicines. Bausch Health Cos is trading at a lower price-to-earnings ratio than Blueprint Medicines, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBausch Health Cos$9.63B0.26-$46M-$0.11-61.00Blueprint Medicines$508.82M16.30-$67.09M-$2.47-51.98 Is BHC or BPMC more profitable? Bausch Health Cos has a net margin of -0.41% compared to Blueprint Medicines' net margin of -27.70%. Blueprint Medicines' return on equity of -64.60% beat Bausch Health Cos' return on equity.Company Net Margins Return on Equity Return on Assets Bausch Health Cos-0.41% -540.45% 5.26% Blueprint Medicines -27.70%-64.60%-17.22% SummaryBlueprint Medicines beats Bausch Health Cos on 9 of the 17 factors compared between the two stocks. Get Bausch Health Cos News Delivered to You Automatically Sign up to receive the latest news and ratings for BHC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BHC vs. The Competition Export to ExcelMetricBausch Health CosMED IndustryMedical SectorNYSE ExchangeMarket Cap$2.54B$3.90B$5.47B$20.52BDividend YieldN/A1.16%5.25%3.76%P/E Ratio-61.006.6127.0027.79Price / Sales0.2611.11435.7540.48Price / Cash0.896.5336.8222.26Price / Book-7.542.657.984.58Net Income-$46M-$109.62M$3.16B$982.91M7 Day Performance-5.63%-2.03%2.40%0.41%1 Month Performance37.50%2.80%2.19%3.59%1 Year Performance-6.74%25.82%33.82%14.47% Bausch Health Cos Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BHCBausch Health Cos3.6945 of 5 stars$6.71-2.3%$7.42+10.5%-7.9%$2.54B$9.63B-61.0020,700BPMCBlueprint Medicines1.5043 of 5 stars$128.18+0.1%$128.06-0.1%+10.4%$8.28B$562.12M-51.89640Insider TradeBBIOBridgeBio Pharma4.6665 of 5 stars$43.18-3.7%$58.85+36.3%+65.2%$8.20B$221.90M-12.23400High Trading VolumeVRNAVerona Pharma PLC American Depositary Share2.6057 of 5 stars$94.58+0.8%$101.10+6.9%+410.6%$8.05B$42.28M-47.2930Positive NewsROIVRoivant Sciences1.5177 of 5 stars$11.27-1.1%$17.50+55.3%+1.3%$7.66B$29.05M-45.08860ELANElanco Animal Health2.3486 of 5 stars$14.29flat$15.17+6.1%+5.7%$7.10B$4.44B19.319,000RVMDRevolution Medicines4.5646 of 5 stars$36.79-0.3%$67.58+83.7%-7.9%$6.85B$11.58M-9.20250Positive NewsLEGNLegend Biotech3.0504 of 5 stars$35.49+2.5%$76.20+114.7%-20.9%$6.52B$627.24M-60.152,609Positive NewsAnalyst ForecastGRFSGrifols4.0825 of 5 stars$9.04+2.0%$10.30+13.9%+7.0%$6.22B$7.81B7.7323,822News CoverageAnalyst UpgradeTGTXTG Therapeutics3.89 of 5 stars$35.99-2.0%$40.80+13.4%+82.1%$5.71B$386.39M149.96290News CoveragePositive NewsLNTHLantheus4.4152 of 5 stars$81.86+0.5%$130.50+59.4%+4.6%$5.66B$1.53B23.26700 Related Companies and Tools Related Companies Blueprint Medicines Alternatives BridgeBio Pharma Alternatives Verona Pharma PLC American Depositary Share Alternatives Roivant Sciences Alternatives Elanco Animal Health Alternatives Revolution Medicines Alternatives Legend Biotech Alternatives Grifols Alternatives TG Therapeutics Alternatives Lantheus Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:BHC) was last updated on 7/9/2025 by MarketBeat.com Staff From Our PartnersA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bausch Health Cos Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bausch Health Cos With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BHC Stock Alerts